PlainRecalls
FDA Drug Moderate Class II Ongoing

Pravastatin Sodium Tablets, USP 80mg, packaged in a) 90-count bottle, NDC 68462-198-90; b) 500-count bottle, NDC 68462-198-05, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430,

Reported: July 24, 2024 Initiated: June 28, 2024 #D-0612-2024

Product Description

Pravastatin Sodium Tablets, USP 80mg, packaged in a) 90-count bottle, NDC 68462-198-90; b) 500-count bottle, NDC 68462-198-05, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430,

Reason for Recall

Failed Dissolution Specifications: results below specifications

Details

Units Affected
a) 145,800 bottles; b) 1,368 bottles
Distribution
USA Nationwide
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Pravastatin Sodium Tablets, USP 80mg, packaged in a) 90-count bottle, NDC 68462-198-90; b) 500-count bottle, NDC 68462-198-05, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430,. Recalled by Glenmark Pharmaceuticals Inc., USA. Units affected: a) 145,800 bottles; b) 1,368 bottles.
Why was this product recalled?
Failed Dissolution Specifications: results below specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on July 24, 2024. Severity: Moderate. Recall number: D-0612-2024.